DJI
+0.47%
SPX
+0.40%
IXIC
+0.24%
FTSE
-0.20%
N225
-0.88%
AXJO
-0.49%
Cg Oncology
CGON
-0.02 (-0.08%)
26.12
USD
At close at Jul 25, 20:47 UTC

Overview

Loading chart...

Key Stats

Market Cap
1.99B
Dividend Yield
0.00%
P/E Ratio
-18.85
EPS
-1.50
Revenue
662.00K
Avg. Volume
2.99M

Recently from Cashu

No Cashu articles
Cg Oncology currently has no Cashu-related articles

About

What does CGON do?
CG Oncology, based in Irvine, California, focuses on developing bladder-sparing therapies for bladder cancer and went public on January 25, 2024. Its key candidates include cretostimogene and BOND-003, both targeting non-muscle invasive bladder cancer.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Join our newsletter to keep up to date with us!
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

© 2024 Cashu PTY LTD.